chr12-21560468-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_021957.4(GYS2):​c.1087A>G​(p.Met363Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.782 in 1,572,172 control chromosomes in the GnomAD database, including 482,680 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.75 ( 42603 hom., cov: 32)
Exomes 𝑓: 0.79 ( 440077 hom. )

Consequence

GYS2
NM_021957.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 2.80

Publications

39 publications found
Variant links:
Genes affected
GYS2 (HGNC:4707): (glycogen synthase 2) The protein encoded by this gene, liver glycogen synthase, catalyzes the rate-limiting step in the synthesis of glycogen - the transfer of a glucose molecule from UDP-glucose to a terminal branch of the glycogen molecule. Mutations in this gene cause glycogen storage disease type 0 (GSD-0) - a rare type of early childhood fasting hypoglycemia with decreased liver glycogen content. [provided by RefSeq, Dec 2009]
GYS2 Gene-Disease associations (from GenCC):
  • glycogen storage disorder due to hepatic glycogen synthase deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=7.3008766E-7).
BP6
Variant 12-21560468-T-C is Benign according to our data. Variant chr12-21560468-T-C is described in ClinVar as Benign. ClinVar VariationId is 261462.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.777 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GYS2NM_021957.4 linkc.1087A>G p.Met363Val missense_variant Exon 8 of 16 ENST00000261195.3 NP_068776.2 P54840
GYS2XM_024448960.2 linkc.1087A>G p.Met363Val missense_variant Exon 8 of 17 XP_024304728.1
GYS2XM_006719063.4 linkc.856A>G p.Met286Val missense_variant Exon 7 of 15 XP_006719126.1
GYS2XM_017019245.3 linkc.1087A>G p.Met363Val missense_variant Exon 8 of 9 XP_016874734.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GYS2ENST00000261195.3 linkc.1087A>G p.Met363Val missense_variant Exon 8 of 16 1 NM_021957.4 ENSP00000261195.2 P54840
ENSG00000285854ENST00000647960.1 linkn.*1089A>G non_coding_transcript_exon_variant Exon 15 of 23 ENSP00000497202.1 A0A3B3IS95
ENSG00000285854ENST00000647960.1 linkn.*1089A>G 3_prime_UTR_variant Exon 15 of 23 ENSP00000497202.1 A0A3B3IS95
ENSG00000285854ENST00000648372.1 linkn.1014A>G non_coding_transcript_exon_variant Exon 8 of 11

Frequencies

GnomAD3 genomes
AF:
0.746
AC:
113390
AN:
151966
Hom.:
42566
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.677
Gnomad AMI
AF:
0.631
Gnomad AMR
AF:
0.741
Gnomad ASJ
AF:
0.689
Gnomad EAS
AF:
0.752
Gnomad SAS
AF:
0.797
Gnomad FIN
AF:
0.810
Gnomad MID
AF:
0.604
Gnomad NFE
AF:
0.782
Gnomad OTH
AF:
0.684
GnomAD2 exomes
AF:
0.770
AC:
193463
AN:
251334
AF XY:
0.770
show subpopulations
Gnomad AFR exome
AF:
0.670
Gnomad AMR exome
AF:
0.788
Gnomad ASJ exome
AF:
0.690
Gnomad EAS exome
AF:
0.749
Gnomad FIN exome
AF:
0.807
Gnomad NFE exome
AF:
0.778
Gnomad OTH exome
AF:
0.733
GnomAD4 exome
AF:
0.786
AC:
1115961
AN:
1420088
Hom.:
440077
Cov.:
27
AF XY:
0.785
AC XY:
556918
AN XY:
709100
show subpopulations
African (AFR)
AF:
0.676
AC:
22076
AN:
32644
American (AMR)
AF:
0.783
AC:
34993
AN:
44684
Ashkenazi Jewish (ASJ)
AF:
0.694
AC:
17965
AN:
25900
East Asian (EAS)
AF:
0.784
AC:
30975
AN:
39488
South Asian (SAS)
AF:
0.792
AC:
67620
AN:
85406
European-Finnish (FIN)
AF:
0.804
AC:
42904
AN:
53362
Middle Eastern (MID)
AF:
0.638
AC:
3632
AN:
5694
European-Non Finnish (NFE)
AF:
0.793
AC:
851208
AN:
1073958
Other (OTH)
AF:
0.756
AC:
44588
AN:
58952
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
10422
20845
31267
41690
52112
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19750
39500
59250
79000
98750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.746
AC:
113485
AN:
152084
Hom.:
42603
Cov.:
32
AF XY:
0.749
AC XY:
55721
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.677
AC:
28097
AN:
41486
American (AMR)
AF:
0.742
AC:
11337
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.689
AC:
2387
AN:
3466
East Asian (EAS)
AF:
0.752
AC:
3881
AN:
5162
South Asian (SAS)
AF:
0.795
AC:
3834
AN:
4822
European-Finnish (FIN)
AF:
0.810
AC:
8573
AN:
10588
Middle Eastern (MID)
AF:
0.612
AC:
180
AN:
294
European-Non Finnish (NFE)
AF:
0.782
AC:
53175
AN:
67970
Other (OTH)
AF:
0.686
AC:
1448
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1452
2904
4355
5807
7259
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
858
1716
2574
3432
4290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.770
Hom.:
161705
Bravo
AF:
0.736
TwinsUK
AF:
0.794
AC:
2945
ALSPAC
AF:
0.792
AC:
3052
ESP6500AA
AF:
0.676
AC:
2980
ESP6500EA
AF:
0.777
AC:
6680
ExAC
AF:
0.768
AC:
93297
Asia WGS
AF:
0.755
AC:
2622
AN:
3478
EpiCase
AF:
0.763
EpiControl
AF:
0.752

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Glycogen storage disorder due to hepatic glycogen synthase deficiency Benign:4
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 23, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.042
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
14
DANN
Benign
0.80
DEOGEN2
Benign
0.22
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-0.70
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.59
T
MetaRNN
Benign
7.3e-7
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
-3.2
N
PhyloP100
2.8
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
2.6
N
REVEL
Benign
0.19
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.081
MPC
0.12
ClinPred
0.0018
T
GERP RS
4.0
Varity_R
0.059
gMVP
0.55
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2306180; hg19: chr12-21713402; COSMIC: COSV53923853; API